Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Waldenstrom Macroglobulinemia
Regimen:
(Rituxan (rituximab) + cyclophosphamide + doxorubicin hydrochloride + prednisone + vincristine)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma: THERAPY FOR PREVIOUSLY TREATED WM/LPL...Useful in Certain Circumstances...Cyclophosphamide/doxorubicin/vincristine/prednisone/rituximab
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login